Digital Therapeutics Sarcopenia Market Opportunities Are Emerging Beyond Traditional Growth Areas
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Digital Therapeutics Sarcopenia Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The market for digital therapeutics targeting sarcopenia has experienced significant expansion recently, with projections indicating a rise from $1.54 billion in 2025 to $1.78 billion by 2026, reflecting a compound annual growth rate of 16.1%. This historical growth trajectory has been bolstered by several key factors, including the increasing prevalence of an aging global population, heightened awareness concerning the health implications of sarcopenia, a growing trend in the adoption of telehealth services, the increasing acceptance of therapeutic solutions delivered via software, and the initial positive outcomes from clinical trials involving digital interventions.
The digital therapeutics market focused on sarcopenia is poised for swift expansion in the upcoming years, projecting a rise to $3.21 billion by 2030, underpinned by a compound annual growth rate (CAGR) of 15.9%. This anticipated growth over the forecast period stems from several key drivers, including a heightened need for managing chronic conditions from home, the increasing incorporation of AI for personalized therapeutic approaches, broader availability of reimbursement for digital health solutions, a greater uptake of remote patient monitoring technologies, and a pronounced emphasis on proactive measures for muscle health. During this same forecast period, significant trends are expected to emerge, such as the wider adoption of individualized digital therapy plans, increased utilization of wearable devices for muscle monitoring, a greater deployment of remote physiotherapy services, the expansion of data-informed strategies for sarcopenia management, and a reinforced focus on engaging patients and ensuring they adhere to their treatment regimens.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27278&type=smp
Digital Therapeutics Sarcopenia Market Growth Momentum: Which Factors Are Influencing Demand?
The increasing incidence of co-occurring health issues is anticipated to be a primary catalyst for the expansion of the digital therapeutics market focused on sarcopenia. These co-occurring conditions, known as comorbidities, involve the simultaneous presence of multiple diseases within one person. Factors such as an aging global population contribute significantly to this rise, as older age groups are more susceptible to developing several chronic ailments due to diminished bodily functions and prolonged exposure to various health hazards. Digital therapeutic solutions designed for sarcopenia offer a valuable approach to mitigating comorbidities, particularly obesity, by encouraging consistent exercise and muscle enhancement activities, thereby aiding metabolic function and curbing excess body fat. Illustrating this trend, by 2035, an estimated 79% of adults grappling with being overweight or obese will reside in lower and middle-income countries, with the global adult population affected by obesity projected to reach 1.53 billion, as reported by the World Obesity Federation in March 2024. Consequently, the growing burden of comorbidities plays a crucial role in fueling the digital therapeutics sarcopenia market’s advancement.
Digital Therapeutics Sarcopenia Market Segmentation Trends And Revenue Drivers
The digital therapeutics sarcopenia market covered in this report is segmented –
1) By Product: Software, Devices, Services
2) By Distribution Channel: Online Platforms, Direct-To-Consumer Digital Channels, Other Distribution Channels
3) By Application: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Rehabilitation Centers, Other End Users
Subsegments:
1) By Software: Mobile Applications, Web-Based Platforms, AI-Powered Monitoring Tools, Exercise And Rehabilitation Programs, Nutritional Guidance Software
2) By Devices: Wearable Fitness Trackers, Smart Scales, Connected Resistance Bands, Electromyography (EMG) Devices, Muscle Strength Assessment Tools
3) By Services: Remote Patient Monitoring Services, Virtual Physiotherapy Sessions, Teleconsultation Services, Personalized Coaching Services, Data Analytics And Reporting Services
Digital Therapeutics Sarcopenia Market Trends Reshaping Industry Growth
In the digital therapeutics market for sarcopenia, leading entities are prioritizing the creation of sophisticated technologies, including drug discovery platforms, with the aim of formulating more precise treatments, boosting therapeutic outcomes, and expediting the provision of individualized care for the decline in muscle mass associated with aging. Such platforms are instrumental in expediting the identification and development of novel pharmaceuticals through the utilization of cutting-edge instruments and techniques. To illustrate, in April 2025, ProFuse Technology, a biotechnology firm headquartered in Israel, introduced an innovative drug discovery platform designed to mitigate muscle deterioration stemming from GLP-1 based weight-loss medications, the natural aging process (sarcopenia), and cancer-related wasting (cachexia). By employing laboratory-cultivated, exceptionally mature muscle tissues that closely replicate in-vivo muscle, the company facilitates rapid and efficient testing and evaluation of potential drug compounds. This sophisticated platform not only lessens the necessity for animal experimentation but also curtails research expenditures. With a growing demand for therapies that preserve muscle mass, ProFuse is diversifying from its cultivated meat ventures into the biopharmaceutical sector, presenting a pioneering strategy to confront the escalating challenges in maintaining muscle health.
#Digital Therapeutics Sarcopenia Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the digital therapeutics sarcopenia market are Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Lark Technologies Inc., Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, Cometa Srl., Koneksa Health Inc., Physitrack PLC, Kaia Health Inc., XRHealth USA Inc., MedRhythms Inc.
Access The Complete Digital Therapeutics Sarcopenia Market Report:
Digital Therapeutics Sarcopenia Market Geographic Distribution And Regional Opportunities
North Americawas the largest region in the digital therapeutics sarcopenia market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics sarcopenia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
